Replies to post #228563 on Biotech Values

[jbog]

Looks like Gilead and Abbvie are close to a tie with total HCV Sales with Abbvie at $632m and Gilead at $630m.

Gilead wrote down it's raw material stockpile because of future sales which isn't promising.